B cell lymphoma (BCL)

Clinical trials for B cell lymphoma (BCL) explained in plain language.

Never miss a new study

Get alerted when new B cell lymphoma (BCL) trials appear

Sign up with your email to follow new studies for B cell lymphoma (BCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Engineered immune cells take on stubborn lymphoma

Disease control Not yet recruiting

This study tests a new approach using a mix of gene-modified immune cells (CAR-T cells) that target multiple proteins found on B cell lymphoma cells. The goal is to see if this combination is safe and can shrink tumors in patients whose cancer has not responded to standard treatm…

Matched conditions: B CELL LYMPHOMA (BCL)

Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control

Last updated Aug 28, 2026 00:00 UTC

B cell lymphoma (BCL)

Get alerted when new B cell lymphoma (BCL) trials appear

Engineered immune cells take on stubborn lymphoma